AI-washing – when AI hype becomes a litigation risk
Lachlan Blair, Ph.D.
Associate Intellectual Property
-
Overview
-
Experience
-
Credentials
-
Insights and events
Lachlan’s background in organic and medicinal chemistry, combined with eight years of experience in patent law, enables him to help life science innovators protect and advance their technologies and businesses. He works with life science companies ranging from early‑stage startups to mature pharmaceutical companies developing treatments, diagnostics, and drug‑delivery platforms across different areas including rare diseases, neurological and metabolic disorders, pain, oncology, and infectious diseases.
Lachlan provides creative strategies to secure robust, global protection for his clients’ innovations, including drafting and prosecuting patent applications and managing extensive patent portfolios with an eye toward meaningful protection in competitive landscapes. He also supports clients engaged in transactions by conducting validity and infringement risk analyses, in addition to offering freedom‑to‑operate and patentability analyses. In addition, Lachlan has experience with pre‑litigation research and risk assessment.
Representative experience
Managed patent portfolios for multiple life science companies.
Advised pharmaceutical companies and private equity firms on major transactions where patents were central assets.
Advised international life science companies on U.S. patent law, including assessing infringement claims and invalidity challenges.
Guided clients on strategies to secure Orange Book listable patents, and to extend patent protection beyond the patent cliff.
Credentials
Education
- Juris Doctor, Suffolk University Law School, Summa Cum Laude, 2024
- Ph.D., Organic Chemistry, University of Auckland, 2016
- B.S., Medicinal Chemistry, University of Auckland, First Class Honors, 2012
Bar admissions and qualifications
- U.S. Patent and Trademark Office
- Massachusetts